Abstract
Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT1A and 5-HT2 drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC–MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT1A receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT1c/5-HT2 receptor agonist), there was no change, and with KET (5-HT2 receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs.
Similar content being viewed by others
Abbreviations
- FST:
-
Forced swimming test
- EPM:
-
Elevated plus maze
- OFT:
-
Open field test
- 5-HT:
-
Serotonin
- 5-HT1A :
-
Serotonin receptor type 1A
- 5-HT2 :
-
Serotonin receptor type 2
- 8-OH:
-
8-Hydroxy-2-(di-n-propylamino)tetralin
- WAY:
-
N-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide
- KET:
-
Ketanserine
- DOI:
-
1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane
- SeF1:
-
Fraction 1 from S. elegans
- SeF2:
-
Fraction 2 from S. elegans
- SeF3:
-
Fraction 3 from S. elegans
- SeF4:
-
Fraction 4 from S. elegans
- OA:
-
Oleanolic acid
- TM:
-
Agarospirol/rosifoliol mixture
References
Aguilar A, Camacho J, Chino S, Jácquez P, López E (1994) Herbario de Medicina del Instituto Mexicano del Seguro Social. Información etnobotánica. México: Instituto Mexicano del Seguro Social pp. 159, 245.
Celada P, Puig M, Amargós-Bosch M, Adell A, Artigas F (2004) The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 29:252–265
Celada P, Bortolozzi A, Artigas F (2013) Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research. CNS Drugs 27:703–716
Crist J, Surprenant A (1987) Evidence that 8-hydroxy-2-(n-dipropylamino) tetralin (8-OH-DPAT) is a selective α2-adrenoceptor antagonist on guinea-pig submucous neurons. Br J Pharmacol 92:341–347
Critchley MA, Handley SL (1987) Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology 93:502–506
Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29:547–569
Diaz S, Maroteaux L (2011) Implication of 5-HT(2B) receptors in the serotonin syndrome. Neuropharmacol 61:495–502
DSM-V. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
Dubovsky SL (2018) Whats is new about new antidepressants? Psychother Psychosom 87:129–139
Fajemiroye JO, Galdino PM, Florentino IR, Da Rocha FF, Ghedini PC, Polepally PR, Zjawiony JK, Costa EA (2014) Plurality of anxiety and depression alteration mechanism by oleanolic acid. J Psychopharmacol 8:923–934
González-Cortazar M, Maldonado-Abarca AM, Jiménez-Ferrer E, Marquina S, Ventura- Zapata E, Zamilpa A, Tortoriello J, Herrera-Ruiz M (2013) Isosakuranetina- 5-O- rutinoside: a new flavanone with antidepressant activity isolated from Salvia elegans Vahl. Molecules 18:13260–13270
Handley SL (1995) 5-hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther 66:103–148
Hedlund PB, Kelly L, Mazur C, Lovenberg T, Sutcliffe JG, Bonaventure P (2004) 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol 487:125–132
Heerlein A (2002) Antidepressant pharmacologic treatments. Rev Chil Neuro-Psiquiat 40:39–51
Herrera-Ruiz M, García Y, Mora S, Díaz G, Viana S, Tortoriello J, Ramírez G (2006) Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans. J Ethnopharmacol 107:53–58
Hutson PH, Dourish CT, Curzon G (1988) Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. Eur J Pharmacol 150:361–366
Jastrzębska-Więsek M, Partyka A, Rychtyk J, Śniecikowska J, Kołaczkowski M, Wesołowska A, Varney MA, Newman-Tancredi A (2018) Activity of serotonin 5-HT1A receptor biased agonists in rat: anxiolytic and antidepressant-like properties. ACS Chem Neurosci 9:1040–1050
Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185
Markou A, Cryan JF (2012) Stress, anxiety and depression: toward new treatment strategies. Neuropharmacology 62:1–2
Mora S, Millán R, Lungenstrass H, Díaz-Véliz G, Morán JA, Herrera-Ruiz M, Tortoriello J (2006) The hydroalcoholic extract of Salvia elegans induces anxiolytic- and antidepressant-like effects in rats. J Ethnopharmacol 106:76–81
Moser PC, Tricklebank MD, Middlemiss DN, Mir AK, Hibert MF, Fozard JR (1990) Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam. Br J Pharmacol 99:343–349
Motta V, Maisonnette S, Morato S, Castrechini P, Brandão ML (1992) Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze. Psychopharmacology 107:135–139
Newman-Tancredi (2011) Biased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disorders. Neuropsychiatry 1:149–164
Okugawa H, Ueda R, Matsumoto K, Kawanishi K, Kayo A (1995) Effect of Jnokoh- eremol and Agarospirol from Agarwood on the central nervous system in mice. Planta Med 62:2–6
Okugawa H, Ueda R, Matsumoto K, Kawanishi K, Kato K (2000) Effects of sesquiterpenoids from “Oriental incenses” on acetic acid-induced writhing and D2 and 5-HT2A receptors in rat brain. Phytomedicine 7:417–422
Onaivi ES, Bishop-Robinson C, Darmani NA, Sandres-Bush E (1995) Behavioral effects of (+/)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus- maze test. Life Sci 57:2455–2466
Porsolt RD, Pichon ML, Jalif M (1977) Depression: a new model sensitive to the antidepressant treatment. Nature 266:730–732
Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3–33
Rosa A, Deiana M, Atzeri A, Corona G, Incani A, Melis MP, Appendino G, Dessì MA (2007) Evaluation of the antioxidant and cytotoxic activity of arzanol, a prenylated alpha-pyrone-phloroglucinol etherodimer from Helichrysum italicum subsp. microphyllum. Chem-Biol Interact 165:117–126
Van Heeringen K, Mann JJ (2014) The Neurobiology of Suicide. Lancet Psychiatry 1:63–72
Varma KR, Maheshwari ML, Bhattacharyya SC (1965) Terpenoids-LXII: The constitution of agarospirol, a sesquiterpenoid with a new skeleton. Tetrahedron 21:115–138
Villalobos-Osorio D, Ramírez-González I, Rojas-Fermín L, Santiago-Silva B, Carmona- Arzola J, Avedaño-Meza M (2014) Composición del aceite esencial y caracterización fisicoquímica de las hojas de Stachytarpheta mutabilis (Jacq.) Vahl. Av Quím 9:15–19
World Health Organization (2017) Report: depression and other common metal disorders. Global Health Estimates, Geneva
Funding
This work was partially supported by Fondo de Investigación en Salud-IMSS number FIS/IMSS/PROT/PRIO/14/029. Martínez-Hernández GB is grateful for the fellowship from CONACyT 558749 and for the complementary support from IMSS 99186327.
Author information
Authors and Affiliations
Contributions
The authors declare that all data were generated in-house and that no paper mill was used.
Antidepressant and anxiolytic behavioral assays, extraction, chromatographic assays, and chemical preparation of samples for S. elegans were demonstrated by M-HGB and V-VG. Experimental design, statistical analysis, manuscript preparation, and pharmacologic analysis were demonstrated by H-RM, J-FE, and R-RR. Chemical UPLC and gases-M analysis were demonstrated by M-GC and TJ.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Martínez-Hernández, G.B., Jiménez-Ferrer, E., González-Cortazar, M. et al. Antidepressant and anxiolytic compounds isolated from Salvia elegans interact with serotonergic drugs. Naunyn-Schmiedeberg's Arch Pharmacol 394, 2419–2428 (2021). https://doi.org/10.1007/s00210-021-02155-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-021-02155-6